Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016156 · ClinicalTrials.gov registry record · NA
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
A NA study, sponsored by St. Jude Children's Research Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03016156 is a NA study that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 1 participants.
The verdict
NCT03016156, a NA study, was terminated before completion, sponsored by St. Jude Children's Research Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study seeks to determine whether a smartphone application called CRADLE (ComputeR Assisted Detection of LEukocoria) has the potential to improve the detection of leukocoria. There will be no impact on participants' health outcome. This study will be performed in two parts, each with a distinct cohort of patients. Part 1 will assess the feasibility of various techniques/conditions for using CRADLE within patients known to have leukocoria. Part 2 will estimate the sensitivity and specificity of CRADLE to detect leukocoria (using the techniques selected from information gathered in Part 1) as compared to an ophthalmoscope, within patients referred to the clinic for suspected leukocoria. PRIMARY OBJECTIVES: * To determine the most effective usage of a camera phone application (CRADLE) to maximize detection of leukocoria in patients with retinoblastoma, congenital cataracts, and glaucoma. * To estimate the sensitivity and specificity of a camera phone application (CRADLE) in detecting leukocoria.
Interventions
- OTHER CRADLE
- OTHER Red reflex testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03016156
The ClinicalTrials.gov registry entry for NCT03016156 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CRADLE is the first listed.
NCT03016156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03016156 about?
NCT03016156 is a clinical study titled "Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma". This study seeks to determine whether a smartphone application called CRADLE (ComputeR Assisted Detection of LEukocoria) has the potential to improve the detection of leukocoria. There will be no impact on participants' health outcome. This study will be performed in two parts, each with a distinct...
What is the current status of trial NCT03016156?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-03-15. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT03016156?
The interventions under investigation include: CRADLE (OTHER), Red reflex testing (OTHER).
Who is sponsoring clinical trial NCT03016156?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.